Literature DB >> 8713487

Adverse drug events related to dosage forms and delivery systems.

I F Uchegbu1, A T Florence.   

Abstract

While some of the adverse events caused by the administration of medicines are specifically attributable to the drug molecule, a proportion arises because of the chemical, biological and physical nature of the formulation. The effects may be compounded by certain patient factors, an incomplete understanding of the behaviour of the formulation or the coadministration of other drugs. This review examines adverse drug reactions and other adverse events arising from the nature of the dosage form or formulation used. These adverse effects may be the result of local irritation/toxicity, hypersensitivity or allergic reactions, systemic effects from essentially local therapies, or idiosyncratic reactions in a small number of individuals. In certain cases where the exact nature of the formulation is unknown, adverse events cannot be attributed to any single ingredient. In addition, the total of all ingredients of a formulation, even where details of the formulation are clear, may give rise to abnormal behaviour of the formulation in vivo. Often the desired objective of a particular specialised formulation leads to an unforseen but related adverse effect, and in certain instances these events are completely unpredictable and at variance with the perceived objectives of the formulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8713487     DOI: 10.2165/00002018-199614010-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  178 in total

1.  Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.

Authors:  R Jones; K Franklin; R Spicer; J Berry
Journal:  Lancet       Date:  1995-08-19       Impact factor: 79.321

2.  Transmucosal penetration of bismuth particles in the human stomach.

Authors:  C U Nwokolo; J F Lewin; M Hudson; R E Pounder
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

3.  Overdose of sustained release verapamil.

Authors:  R J Rankin; I R Edwards
Journal:  N Z Med J       Date:  1990-04-11

4.  Contamination of injection ports on intravenous cannulae.

Authors:  E P Oberhammer
Journal:  Lancet       Date:  1980-11-08       Impact factor: 79.321

5.  Anaphylactic reactions to liposomal amphotericin.

Authors:  R B Laing; L J Milne; C L Leen; G P Malcolm; A J Steers
Journal:  Lancet       Date:  1994-09-03       Impact factor: 79.321

6.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

Review 7.  The problems with high dose pancreatic enzyme preparations.

Authors:  C J Taylor
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

8.  Dissolution of phenytoin precipitate with sodium bicarbonate in an occluded central venous access device.

Authors:  K I Akinwande; D M Keehn
Journal:  Ann Pharmacother       Date:  1995 Jul-Aug       Impact factor: 3.154

9.  Two cases of therapeutic failure associated with levothyroxine brand interchange.

Authors:  P M Copeland
Journal:  Ann Pharmacother       Date:  1995-05       Impact factor: 3.154

10.  Increase of plasma nonesterified fatty acid concentration and decrease of albumin binding affinity after intravenous injection of glycocholate-lecithin mixed micelles.

Authors:  T W Guentert; B M Frey; E Luedin; S Heinzl; R Brodersen
Journal:  J Lab Clin Med       Date:  1990-07
View more
  5 in total

1.  Pancreatic enzyme preparations.

Authors:  M A Rudmann
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

2.  Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.

Authors:  Dorsey M Bass; Mary Prevo; Deborah S Waxman
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress.

Authors:  Saba Naqvi; Mohammad Samim; Mz Abdin; Farhan Jalees Ahmed; An Maitra; Ck Prashant; Amit K Dinda
Journal:  Int J Nanomedicine       Date:  2010-11-16

4.  Surface Engineered Iron Oxide Nanoparticles Generated by Inert Gas Condensation for Biomedical Applications.

Authors:  Aver Hemben; Iva Chianella; Glenn John Thomas Leighton
Journal:  Bioengineering (Basel)       Date:  2021-03-15

5.  Development of an adverse drug event network to predict drug toxicity.

Authors:  Qier Wu; Olivier Taboureau; Karine Audouze
Journal:  Curr Res Toxicol       Date:  2020-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.